Angiotensinogen Genotype, Sodium Reduction, Weight Loss, and Prevention of Hypertension : Trials of Hypertension Prevention, Phase II

Hypertension - United States
doi 10.1161/01.hyp.32.3.393
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Weight and Sodium Reduction for the Prevention of Hypertension: A Comparison of Group Treatment and Individual Counseling.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1983English

Salt Reduction in a Population for the Prevention of Hypertension

Environmental Health and Preventive Medicine
MedicineEnvironmentalPublic HealthOccupational Health
2004English

An Ayurvedic Prevention and Management of Hypertension

Environment Conservation Journal
2019English

Physical Activity and the Prevention of Hypertension

Current Hypertension Reports
Internal Medicine
2013English

2. Treatment of Hypertension for Stroke Prevention (M3-A Stroke and Management of Hypertension)

Japanese Journal of Neurosurgery
SurgeryNeurology
2004English

Haplotypes of Angiotensinogen in Essential Hypertension

American Journal of Human Genetics
Genetics
1997English

Prevention and Treatment of Hypertension in Everyday Pharmacy Practice

Arhiv za Farmaciju
PharmacologyPharmaceutical Science
2017English

Impact of Social Media on Prevention of Arterial Hypertension

HYPERTENSION
2016English

Hypertension in Aging: Physical Activity as Primary Prevention

European Review of Aging and Physical Activity
GerontologyGeriatrics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy